Home » FibroGen names VP, technical development
FibroGen names VP, technical development
September 12, 2011
FibroGen has named Michael Martinelli, Ph.D., vice president, technical development. In this role, Martinelli is responsible for the chemistry, manufacturing, and controls (CMC) development activities for FibroGen’s most advanced small molecule clinical candidates.
Martinelli brings 25 years of drug development experience from leadership roles in pharmaceutical research & development. He most recently served as vice president, pharmaceutical development, for Arena Pharmaceuticals.
Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials
Learn More Here